We are live on
!
Find out more
NSEDCP
NJ State Employees Deferred Compensation Plan Portfolio holdings
AUM
$906M
1-Year Est. Return
24.85%
This Fund
S&P 500
This Quarter
Est. Return
-8.2%
1 Year Est. Return
+24.85%
3 Year Est. Return
+127.22%
5 Year Est. Return
+201.43%
10 Year Est. Return
+564.84%
AUM
$462M
AUM Growth
-$51.6M
(-10%)
Cap. Flow
-$441K
Cap. Flow
% of AUM
-0.1%
Top 10 Holdings %
Top 10 Hldgs %
15.6%
Holding
395
New
18
Increased
8
Reduced
14
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$2.31M |
| 2 |
AbbVie
ABBV
|
+$1.95M |
| 3 |
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
|
+$1.27M |
| 4 |
Geron
GERN
|
+$1.18M |
| 5 |
Kraft Heinz
KHC
|
+$1.16M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$1.93M |
| 2 |
AMAG
AMAG Pharmaceuticals
AMAG
|
+$1.86M |
| 3 |
AEC
ASSOCIATED ESTATES REALTY CORP
AEC
|
+$1.72M |
| 4 |
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
|
+$1.3M |
| 5 |
PLL
PALL CORP
PLL
|
+$1.25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.61% |
| 2 | Financials | 14.94% |
| 3 | Healthcare | 14.92% |
| 4 | Industrials | 11.55% |
| 5 | Consumer Staples | 9.04% |
Similar funds
IAM
BFS
MSAM
SAM
CP
EAM
HWM
BVDMP
NJ State Employees Deferred Compensation Plan's Q3 2015 Portfolio in Review
As of Q3 2015, NJ State Employees Deferred Compensation Plan held 395 positions worth $462M, down 10% from $514M the previous quarter. Its ten largest holdings account for 16% of the portfolio.
NJ State Employees Deferred Compensation Plan's Q3 2015 filing shows 18 new, 8 increased, 14 reduced and 13 closed positions. Its largest new stake was Biogen: 7,000 shares worth $2.04M. The largest sale was Johnson & Johnson, an estimated $1.93M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- NJ State Employees Deferred Compensation Plan's largest Q3 2015 buy was Biogen: 7,000 shares worth $2.04M.
- NJ State Employees Deferred Compensation Plan added most to AbbVie in Q3 2015, an estimated $1.95M increase.
- NJ State Employees Deferred Compensation Plan's biggest Q3 2015 reduction was Johnson & Johnson, cutting an estimated $1.93M.
- NJ State Employees Deferred Compensation Plan fully exited ASSOCIATED ESTATES REALTY CORP in Q3 2015, selling an estimated $1.72M.
- NJ State Employees Deferred Compensation Plan's ten largest holdings make up 16% of its $462M portfolio in Q3 2015.
- NJ State Employees Deferred Compensation Plan opened 18 new positions and closed 13 in Q3 2015.
- NJ State Employees Deferred Compensation Plan's portfolio value fell 10% quarter-over-quarter to $462M.
Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q3 2015, filed 2 Nov 2015.